Paxlovid's promise fades: Vaccinated seniors see minimal COVID-19 protection
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.
WINK NEWS7h
Ave Maria gator grabs attention with football stuck in mouth
A gator with a mouthful of pigskin! A WINK News viewer from Ave Maria captured a photo of the animal that has become the ...
WINK NEWS13h
FGCU students voice concerns over proposed campus gun legislation
New legislation is stirring concerns among students at Florida Gulf Coast University (FGCU) as a bill proposes expanding ...
infectiousdiseaseadvisor.com1d
COVID-19 Omicron Era: Immunocompromised Benefited From Tixagevimab-Cilgavimab
Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.
Too Old to Operate1d
Immunocompromised Status and COVID-19 Mortality Risk
The following is a summary of “60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden,” ...
Medscape1d
Vasculitis Patients Need Multiple COVID Vaccine Boosters
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
The Conversationalist on MSN2d
Should Greek Life Be Abolished? Gen Z Weighs In
The Conversationalist dives into the debate on Greek life, exploring both its positive impact and its controversies. Gen Z voices discuss the role of fraternities and sororities in campus culture, ...